4-8005201-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001130083.2(ABLIM2):c.1618+2858G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.259 in 437,630 control chromosomes in the GnomAD database, including 15,443 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.25 ( 5076 hom., cov: 33)
Exomes 𝑓: 0.26 ( 10367 hom. )
Consequence
ABLIM2
NM_001130083.2 intron
NM_001130083.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.133
Publications
5 publications found
Genes affected
ABLIM2 (HGNC:19195): (actin binding LIM protein family member 2) Predicted to enable actin filament binding activity. Predicted to be involved in lamellipodium assembly. Predicted to act upstream of or within positive regulation of transcription by RNA polymerase II. Located in actin cytoskeleton. [provided by Alliance of Genome Resources, Apr 2022]
MIR95 (HGNC:31647): (microRNA 95) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.303 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ABLIM2 | NM_001130083.2 | c.1618+2858G>A | intron_variant | Intron 16 of 20 | ENST00000447017.7 | NP_001123555.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.250 AC: 38094AN: 152118Hom.: 5080 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
38094
AN:
152118
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.264 AC: 75219AN: 285394Hom.: 10367 AF XY: 0.261 AC XY: 41277AN XY: 158034 show subpopulations
GnomAD4 exome
AF:
AC:
75219
AN:
285394
Hom.:
AF XY:
AC XY:
41277
AN XY:
158034
show subpopulations
African (AFR)
AF:
AC:
1574
AN:
8524
American (AMR)
AF:
AC:
3701
AN:
27294
Ashkenazi Jewish (ASJ)
AF:
AC:
2527
AN:
7564
East Asian (EAS)
AF:
AC:
2721
AN:
11362
South Asian (SAS)
AF:
AC:
12532
AN:
54178
European-Finnish (FIN)
AF:
AC:
4580
AN:
19068
Middle Eastern (MID)
AF:
AC:
252
AN:
894
European-Non Finnish (NFE)
AF:
AC:
43905
AN:
143802
Other (OTH)
AF:
AC:
3427
AN:
12708
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
2580
5161
7741
10322
12902
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
328
656
984
1312
1640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.250 AC: 38085AN: 152236Hom.: 5076 Cov.: 33 AF XY: 0.244 AC XY: 18137AN XY: 74436 show subpopulations
GnomAD4 genome
AF:
AC:
38085
AN:
152236
Hom.:
Cov.:
33
AF XY:
AC XY:
18137
AN XY:
74436
show subpopulations
African (AFR)
AF:
AC:
7726
AN:
41558
American (AMR)
AF:
AC:
2797
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
1183
AN:
3472
East Asian (EAS)
AF:
AC:
1238
AN:
5182
South Asian (SAS)
AF:
AC:
1058
AN:
4826
European-Finnish (FIN)
AF:
AC:
2396
AN:
10594
Middle Eastern (MID)
AF:
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20861
AN:
67982
Other (OTH)
AF:
AC:
525
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1478
2955
4433
5910
7388
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
396
792
1188
1584
1980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
729
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.